MediGene and Pharmanova Sign Agreement for the Commercialization of Veregen in Southeastern Europe
08-Sep-2011 -
MediGene AG has signed an exclusive license and supply agreement with Pharmanova d.o.o. for the supply and commercialization of Veregen® ointment in Serbia, Bosnia and Herzegovina, Montenegro, Macedonia, Croatia, Slovenia, and Albania, for the treatment of genital warts. MediGene is entitled to ...
Albania
Bosnia and Herzegowina
Croatia (Hrvatska)
+5